NASS Updated Spinal Surgery Coverage Recommendations

The North American Spine Society revised standards for rhBMP-2 usage in spinal fusion procedures.

Updated on Oct. 5, 2026 in Healthcare

Isometric editorial illustration of a titanium spinal rod and bone-graft scaffold on a surgical tray, representing updated medical coverage standards. — The North American Spine Society updated coverage recommendations for rhBMP-2 in spinal fusion surgeries to better support high-risk adult patients. AI Illustration. Upload story photo >

Live Poll

Should medical organizations favor risk-stratified standards over generalized guidelines for complex surgical procedures?

The North American Spine Society has released updated coverage recommendations for the use of rhBMP-2 in spinal fusion surgery. The new guidelines expand support for the treatment in adult patients who face a high risk of nonunion.

Why it matters

The revision was prompted by findings from initial FDA investigational device exemption studies and an independent 2013 data reanalysis. These updates aim to better align clinical guidance with patient-specific risk profiles for bone formation success.

The revised guidelines replace the 2014 standard for rhBMP-2 usage. Clinical criteria now include patients with osteoporosis, radiation history, and metabolic factors like smoking or diabetes.

The players

North American Spine Society

The North American Spine Society is a multidisciplinary medical organization that provides clinical guidelines and education for spinal care professionals.

The details

Physicians are now advised to document specific patient nonunion risk factors to streamline prior authorization workflows. These factors include multilevel surgeries, insufficient iliac crest availability, and pre-existing metabolic conditions.

The independent reanalysis of patient data was commissioned in 2013.
The previous NASS coverage standards were established in 2014.
NASS announced the revised coverage recommendations on October 5, 2026.

Market Landscape

These updated recommendations mirror long-term shifts in medical standards based on the FDA investigational device exemption process. By formalizing these guidelines, NASS is positioning its membership to better navigate the evolving prior authorization environment set by national insurers.

Patients may find that prior authorization for spinal fusion procedures involving rhBMP-2 is now more clearly defined based on their specific health history. Individuals with conditions like diabetes or a history of smoking could see more consistent access to these treatments under the updated clinical standards.

The takeaway

These changes emphasize the importance of thorough clinical documentation for patients seeking advanced spinal fusion options. Patients should consult their surgeons to see if their specific risk factors qualify them for expanded coverage under the new guidelines.